These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 25582113
1. The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells. Hirakawa H, Fujisawa H, Masaoka A, Noguchi M, Hirayama R, Takahashi M, Fujimori A, Okayasu R. Cancer Med; 2015 Mar; 4(3):426-36. PubMed ID: 25582113 [Abstract] [Full Text] [Related]
2. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model. Nam S, Kim H, Hong D, Park JB, Kim SJ. Anticancer Res; 2017 Nov; 37(11):6291-6302. PubMed ID: 29061812 [Abstract] [Full Text] [Related]
3. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells. Ko JC, Chen HJ, Huang YC, Tseng SC, Weng SH, Wo TY, Huang YJ, Chiu HC, Tsai MS, Chiou RY, Lin YW. Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143 [Abstract] [Full Text] [Related]
6. p53 independent radio-sensitization of human lymphoblastoid cell lines by Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Fujii Y, Kato T, Kubota N, Fujimori A, Niwa O, Okayasu R. Oncol Rep; 2010 Jan; 23(1):199-203. PubMed ID: 19956882 [Abstract] [Full Text] [Related]
11. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation. Lee Y, Sunada S, Hirakawa H, Fujimori A, Nickoloff JA, Okayasu R. Mol Cancer Ther; 2017 Jan 05; 16(1):16-24. PubMed ID: 28062703 [Abstract] [Full Text] [Related]
14. Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization. Russell JS, Burgan W, Oswald KA, Camphausen K, Tofilon PJ. Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3749-55. PubMed ID: 14506167 [Abstract] [Full Text] [Related]
15. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells. Ohba S, Hirose Y, Yoshida K, Yazaki T, Kawase T. J Neurosurg; 2010 Jan 01; 112(1):33-42. PubMed ID: 19408974 [Abstract] [Full Text] [Related]
17. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery. Jiang J, Lu Y, Li Z, Li L, Niu D, Xu W, Liu J, Fu L, Zhou Z, Gu Y, Xia F. Invest New Drugs; 2017 Jun 01; 35(3):251-259. PubMed ID: 28111726 [Abstract] [Full Text] [Related]
19. Dimeric ansamycins--a new class of antitumor Hsp90 modulators with prolonged inhibitory activity. Zhang H, Yang YC, Zhang L, Fan J, Chung D, Choi D, Grecko R, Timony G, Karjian P, Boehm M, Burrows F. Int J Cancer; 2007 Feb 15; 120(4):918-26. PubMed ID: 17131314 [Abstract] [Full Text] [Related]